This study investigates the use of electronic health records (EHR) to validate diagnostic codes for chlamydia infections. The purpose is to determine if the TriNetX database can be a reliable source for chlamydia-related research. The study aims to assess the accuracy of ICD-10-CM codes for identifying chlamydia cases and to …
This study investigates the experiences of individuals with stage 2 Type 1 diabetes in the United States. The study compares those who have received an infusion with an investigational medication and those who have not.Participants will provide information on their quality of life, diabetes-related anxiety, and how they manage their …
This study investigates atopic dermatitis in adolescents and adults who begin or change systemic treatments.The study focuses on understanding the patient journey and evaluating the safety and outcomes of treatments for atopic dermatitis in real-world settings.Who can participate: Participants must be 12 years or older with a confirmed diagnosis of …
This study investigates the long-term safety and effectiveness of therapies for non-neoplastic hematologic disorders. The purpose is to collect data from participants with various blood disorders, such as hemophilia, von Willebrand Disease, and congenital platelet disorders, over a period of at least 15 years. Participants will be grouped into specific …
This study investigates the effects of atopic dermatitis (AD) on pregnancy outcomes. This observational study will compare the incidence of adverse pregnancy outcomes, such as miscarriage or stillbirth, and the prevalence of adverse infant outcomes, like major congenital malformations or being small for gestational age, in women with AD who …
This study investigates the long-term outcomes of using an investigational medication in people with Stage 2 Type 1 Diabetes. The study focuses on understanding how the investigational medication affects the quality of life and disease management over time. It aims to gather insights into the emotional and psychosocial aspects associated …
This study investigates the effects of exposure to an investigational vaccine during pregnancy. The purpose is to assess maternal, obstetrical, pregnancy, neonatal, and infant outcomes among women who were vaccinated with the investigational vaccine during pregnancy or in the 30 days before their last menstrual period.Participants in this observational study …
This study investigates the safety of an investigational medication when used by women during pregnancy and lactation. The purpose is to collect data on the effects of the medication on pregnancy outcomes, maternal health, and the developing child. Outcomes in infants exposed to the medication will be assessed, including their …
This study investigates the long-term safety and immune response to an investigational therapy in children under 2 years old with a condition called Acid Sphingomyelinase Deficiency (ASMD). The purpose of this study is to observe how the investigational therapy affects children with this condition over time.Participants in the study will …
This study investigates chronic spontaneous urticaria (CSU) and aims to understand how patients respond to an investigational medication in real-world settings. The purpose of this study is to gather information on the condition and treatment from medical files and patient reports.The study focuses on evaluating the safety and effectiveness of …
